PT97477A - Processo de preparacao de composicoes farmaceuticas a base de antagonistas dos receptores 5-ht4 - Google Patents

Processo de preparacao de composicoes farmaceuticas a base de antagonistas dos receptores 5-ht4

Info

Publication number
PT97477A
PT97477A PT97477A PT9747791A PT97477A PT 97477 A PT97477 A PT 97477A PT 97477 A PT97477 A PT 97477A PT 9747791 A PT9747791 A PT 9747791A PT 97477 A PT97477 A PT 97477A
Authority
PT
Portugal
Prior art keywords
receptor antagonists
pharmaceutical compositions
compositions based
preparing pharmaceutical
preparing
Prior art date
Application number
PT97477A
Other languages
English (en)
Other versions
PT97477B (pt
Inventor
Alberto Julio Kaumann
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT97477A publication Critical patent/PT97477A/pt
Publication of PT97477B publication Critical patent/PT97477B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polarising Elements (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PT97477A 1990-04-26 1991-04-24 Processo de preparacao de composicoes farmaceuticas a base de antagonistas dos receptores 5-ht4 PT97477B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009389A GB9009389D0 (en) 1990-04-26 1990-04-26 Treatment

Publications (2)

Publication Number Publication Date
PT97477A true PT97477A (pt) 1992-01-31
PT97477B PT97477B (pt) 1998-08-31

Family

ID=10675031

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97477A PT97477B (pt) 1990-04-26 1991-04-24 Processo de preparacao de composicoes farmaceuticas a base de antagonistas dos receptores 5-ht4

Country Status (14)

Country Link
EP (1) EP0526540B1 (pt)
JP (2) JPH05509293A (pt)
AT (1) ATE181668T1 (pt)
AU (1) AU653521B2 (pt)
CA (1) CA2081344C (pt)
DE (1) DE69131398T2 (pt)
DK (1) DK0526540T3 (pt)
ES (1) ES2134774T3 (pt)
GB (1) GB9009389D0 (pt)
GR (1) GR3031042T3 (pt)
IE (1) IE911383A1 (pt)
PT (1) PT97477B (pt)
WO (1) WO1991016045A2 (pt)
ZA (1) ZA913071B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
WO1994008965A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5684003A (en) * 1994-10-20 1997-11-04 Nisshin Flour Milling Co., Ltd. 5-HT4 receptor agonists
CA2418904A1 (en) * 2000-08-07 2002-02-14 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CA2569654C (en) 2004-06-15 2010-12-21 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP2153830A1 (en) * 2008-08-07 2010-02-17 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of stroke or transient ischemic attack
JP6574773B2 (ja) 2014-07-30 2019-09-11 株式会社アエタスファルマ １，４−ベンゾチアゼピン−１−オキシド誘導体の光学異性体、及びそれを用いた医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
US4731643A (en) * 1985-10-21 1988-03-15 International Business Machines Corporation Logic-circuit layout for large-scale integrated circuits

Also Published As

Publication number Publication date
EP0526540B1 (en) 1999-06-30
ES2134774T3 (es) 1999-10-16
ZA913071B (en) 1992-11-25
CA2081344A1 (en) 1991-10-27
EP0526540A1 (en) 1993-02-10
DK0526540T3 (da) 1999-11-22
CA2081344C (en) 2003-10-21
GR3031042T3 (en) 1999-12-31
JP2003267890A (ja) 2003-09-25
DE69131398T2 (de) 2000-03-02
AU653521B2 (en) 1994-10-06
DE69131398D1 (de) 1999-08-05
WO1991016045A3 (en) 1991-12-26
IE911383A1 (en) 1991-11-06
GB9009389D0 (en) 1990-06-20
PT97477B (pt) 1998-08-31
AU7768091A (en) 1991-11-11
JPH05509293A (ja) 1993-12-22
WO1991016045A2 (en) 1991-10-31
ATE181668T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
NO924619D0 (no) (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol
IT1240418B (it) Particelle sferiche di silice-allumina amorfe e procedimento per la loro preparazione.
SE9002522D0 (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
FI921609A7 (fi) Menetelmiä ja koostumuksia luun parantamiseksi
FI904911A0 (fi) Menetelmä jarosiittipitoisten jäännösten käsittelemiseksi
NO900063L (no) Fremgangsmaate for sanntid-simulering.
PT97477A (pt) Processo de preparacao de composicoes farmaceuticas a base de antagonistas dos receptores 5-ht4
FI904695A7 (fi) Viruksenvastaiset aineet ja menetelmä AZT:n viruksenvastaisen vaikutuk sen lisäämiseksi
NL193399B (nl) Injecteerbare implantsamenstelling voor gebruik bij reconstructieve chirurgische behandelingen.
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
NO913686L (no) Fremgangsmaate for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmaaten.
IT1240318B (it) Formulazione emulsionante perfezionata
BR9708109A (pt) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinametanol no tratamento de distúrbios depressivos e distúrbios bipolares
DK0378456T3 (da) Tetralinderivater
KR900015713A (ko) 분무용 겔 기제와 이것을 사용한 분무용 겔제
ES2045008T3 (es) Procedimiento para la obtencion de preparados en combinacion antidepresivos.
NO930362L (no) Fremgangsmaate for opptrening, samt artikler for dette
FI901363A7 (fi) Tetrahydronaftaliinijohdannaisia
IT1230254B (it) Procedimento e dispositivo per la realizzazione di pannelli.
NO922437D0 (no) Terapeutisk aktive fluorsubstituerte benzimidazoler, fremgangsmaate for deres fremstilling samt deres anvendelse
KR910000522U (ko) 평판으로 된 일력 협지구
IT8921426A0 (it) Processo per la preparazione di monobattami ed intermedio di preparazione.
BR8905067A (pt) Aperfeicoamento em implantes ortopedicos

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910913

FG3A Patent granted, date of granting

Effective date: 19980512

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20061113